Title : The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway.

Pub. Date : 2016 Sep 14

PMID : 27624942






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis. Tricarboxylic Acids isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens
2 The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis. Tricarboxylic Acids isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens
3 Our results provide an additional molecular mechanism for the oncogenic activity of mutant IDH1/2 by revealing an unprecedented link between TCA cycle defects and positive modulation of mTOR function downstream of the canonical PI3K/AKT/TSC1-2 pathway. Tricarboxylic Acids isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens